Literature DB >> 21029139

The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice.

A M Brand1, M de Kwaadsteniet, L M T Dicks.   

Abstract

AIMS: To determine the ability of nisin F to control systematic infection caused by Staphylococcus aureus, using C57BL/6 mice as a model. METHODS AND
RESULTS: Twelve mice were intraperitoneally injected with 1 × 10(8) viable cells of Staph. aureus Xen 36 containing the modified Photorhabdus luminescence luxABCDE operon on plasmid pAUL-A Tn4001. After 4 h, six mice were intraperitoneally injected with 640 arbitrary units (AU) nisin F, and six were injected with sterile saline. Six mice, not infected with Staph. aureus, were treated with nisin F, and six not infected were left untreated. The viability of Staph. aureus Xen 36 was monitored over 48 h by recording photon emission levels. Nisin F suppressed Staph. aureus for 15 min in vivo. No abnormalities were recorded in blood analyses and internal organs of mice treated with nisin F.
CONCLUSIONS: Nisin F suppressed the growth of Staph. aureus in the peritoneal cavity for at least 15 min. Re-emergence of Staph. aureus bioluminescence over the next 44 h suggests that nisin F was inactivated, most probably by proteolytic enzymes. SIGNIFICANCE AND IMPACT OF THE STUDY: A single dosage of nisin F administered in the peritoneal cavity controlled the growth of Staph. aureus for at least 15 min in vivo.
© 2010 The Authors. Letters in Applied Microbiology 51, 645-649 © 2010 The Society for Applied Microbiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21029139     DOI: 10.1111/j.1472-765X.2010.02948.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  27 in total

1.  Mouse model of chronic post-arthroplasty infection: noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study.

Authors:  Jonathan R Pribaz; Nicholas M Bernthal; Fabrizio Billi; John S Cho; Romela Irene Ramos; Yi Guo; Ambrose L Cheung; Kevin P Francis; Lloyd S Miller
Journal:  J Orthop Res       Date:  2011-08-11       Impact factor: 3.494

2.  In vivo excitation of nanoparticles using luminescent bacteria.

Authors:  Joe Dragavon; Samantha Blazquez; Abdessalem Rekiki; Chelsea Samson; Ioanna Theodorou; Kelly L Rogers; Régis Tournebize; Spencer L Shorte
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

3.  Surface glycosaminoglycans protect eukaryotic cells against membrane-driven peptide bacteriocins.

Authors:  Rebeca Martín; Susana Escobedo; Carla Martín; Ainara Crespo; Luis M Quiros; Juan E Suarez
Journal:  Antimicrob Agents Chemother       Date:  2014-10-20       Impact factor: 5.191

Review 4.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

Review 5.  Anti-infective properties of bacteriocins: an update.

Authors:  Riadh Hammami; Benoit Fernandez; Christophe Lacroix; Ismail Fliss
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

Review 6.  Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.

Authors:  Melinda A Engevik; James Versalovic
Journal:  Microbiol Spectr       Date:  2017-10

Review 7.  Features and applications of Ent35-MccV hybrid bacteriocin: current state and perspectives.

Authors:  S A Navarro; L Lanza; L Acuña; A Bellomio; Miriam C Chalón
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-16       Impact factor: 4.813

8.  The Effects of Continuous In Vivo Administration of Nisin on Staphylococcus aureus Infection and Immune Response in Mice.

Authors:  A M Brand; C Smith; L M T Dicks
Journal:  Probiotics Antimicrob Proteins       Date:  2013-12       Impact factor: 4.609

9.  Release of Enterococcus mundtii Bacteriocin ST4SA from Self-Setting Brushite Bone Cement.

Authors:  Anton D van Staden; Tiaan D J Heunis; Leon M T Dicks
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

10.  In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.

Authors:  Alexandra I Stavrakis; Suwei Zhu; Vishal Hegde; Amanda H Loftin; Alyssa G Ashbaugh; Jared A Niska; Lloyd S Miller; Tatiana Segura; Nicholas M Bernthal
Journal:  J Bone Joint Surg Am       Date:  2016-07-20       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.